1-2 of 2
Zhaoyu Yin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results from an Open-Label, Multicenter, Expanded Treatment Protocol (ETP) Phase (Ph) 3b Study of Ruxolitinib (RUX) in Patients (Pts) with Polycythemia Vera (PV) Who Were Hydroxyurea (HU) Resistant or Intolerant and for Whom No Alternative Treatment (Tx) Was Available

Lynda Foltz, MD FRCPC, Gian-Matteo Pica, MD, Hacene Zerazhi, Jan Van Droogenbroeck, MD, Sorin Visanica, MD, Enrique Báez de la Fuente, MD, Brian Leber, MD, Antonio Medina de Almeida, MD PhD, Dana Ranta, MD, Mauricio Reyes Cartes, MD, Jean-Jacques Kiladjian, MD PhD, Linda Chrit, PhD, Zhaoyu Yin, PhD, Juliane Morando, MD, Timothy Devos
Journal: Blood
Blood (2018) 132 (Supplement 1): 1774.
https://doi.org/10.1182/blood-2018-99-111479
Published: 2018
Journal Articles

Safety and Efficacy of Ruxolitinib (rux) in an Open-Label, Multicenter, Expanded Treatment Protocol in Patients (Pts) with Polycythemia Vera (PV) Who Are Hydroxyurea (HU) Resistant or Intolerant and for Whom No Alternative Treatments Are Available

Timothy Devos, MD, Gian Matteo Pica, MD, Hacene Zerazhi, Jan Van Droogenbroeck, Sorin Visanica, Enrique Báez de la Fuente, Brian Leber, MD, Antonio Medina de Almeida, MD PhD, Dana Ranta, Tomasa Martinez, Jean-Jacques Kiladjian, MD PhD, Linda Chrit, Zhaoyu Yin, Julian Perez Ronco, Lynda Foltz
Journal: Blood
Blood (2017) 130 (Supplement 1): 2918.
https://doi.org/10.1182/blood.V130.Suppl_1.2918.2918
Published: 2017